TY - JOUR
T1 - DC-SIGN+ Macrophages Control the Induction of Transplantation Tolerance
AU - Conde, Patricia
AU - Rodriguez, Mercedes
AU - van der Touw, William
AU - Jimenez, Ana
AU - Burns, Matthew
AU - Miller, Jennifer
AU - Brahmachary, Manisha
AU - Chen, Hui ming
AU - Boros, Peter
AU - Rausell-Palamos, Francisco
AU - Yun, Tae Jin
AU - Riquelme, Paloma
AU - Rastrojo, Alberto
AU - Aguado, Begoña
AU - Stein-Streilein, Joan
AU - Tanaka, Masato
AU - Zhou, Lan
AU - Zhang, Junfeng
AU - Lowary, Todd L.
AU - Ginhoux, Florent
AU - Park, Chae Gyu
AU - Cheong, Cheolho
AU - Brody, Joshua
AU - Turley, Shannon J.
AU - Lira, Sergio A.
AU - Bronte, Vincenzo
AU - Gordon, Siamon
AU - Heeger, Peter S.
AU - Merad, Miriam
AU - Hutchinson, James
AU - Chen, Shu Hsia
AU - Ochando, Jordi
N1 - Funding Information:
We thank Andres Hidalgo (Centro Nacional de Investigaciones Cardiovasculares, ISCIII) and Emmanuel Gautier (Department of Pathology & Immunology, Washington University) for critical review of the manuscript. We acknowledge the technical contributions of the Flow Cytometry, Microsurgery, and the Biorepository/Pathology Centers of Research Excellence at Mount Sinai, and the Alberta Glycomics Centre for their help on the LNFPIII synthesis. Acknowledgments to Marcy Kuentzel and Sridar Chittur at the University of Albany Center for Functional Genomics Microarray Core facility for their assistance in generating the microarray data. This work was supported by the COST Action BM1305: Action to Focus and Accelerate Cell Tolerogenic Therapies (A FACTT), the Mount Sinai Recanati/Miller Transplantation Institute developmental funds, AST/Pfizer Basic Science Faculty Development Grant, Ministerio de Educación y Ciencia SAF2010-15062, SAF2013-48834-R, and Fundación Mutua Madrileña grants to J.O. A portion of this work appears as part of the doctoral thesis of P.C.
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/6/16
Y1 - 2015/6/16
N2 - Tissue effector cells of the monocyte lineage can differentiate into different cell types with specific cell function depending on their environment. The phenotype, developmental requirements, and functional mechanisms of immune protective macrophages that mediate the induction of transplantation tolerance remain elusive. Here, we demonstrate that costimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8+ Tcell immunity and promoted CD4+Foxp3+ Treg cell expansion in numbers. Mechanistically, that simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signaling was required for production of immunoregulatory IL-10 associated with prolonged allograft survival. Deletion of DC-SIGN-expressing macrophages invivo, interfering with their CSF1-dependent development, or preventing the DC-SIGN signaling pathway abrogated tolerance. Together, the results provide new insights into the tolerogenic effects of costimulatory blockade and identify DC-SIGN+ suppressive macrophages as crucial mediators of immunological tolerance with the concomitant therapeutic implications in the clinic.
AB - Tissue effector cells of the monocyte lineage can differentiate into different cell types with specific cell function depending on their environment. The phenotype, developmental requirements, and functional mechanisms of immune protective macrophages that mediate the induction of transplantation tolerance remain elusive. Here, we demonstrate that costimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8+ Tcell immunity and promoted CD4+Foxp3+ Treg cell expansion in numbers. Mechanistically, that simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signaling was required for production of immunoregulatory IL-10 associated with prolonged allograft survival. Deletion of DC-SIGN-expressing macrophages invivo, interfering with their CSF1-dependent development, or preventing the DC-SIGN signaling pathway abrogated tolerance. Together, the results provide new insights into the tolerogenic effects of costimulatory blockade and identify DC-SIGN+ suppressive macrophages as crucial mediators of immunological tolerance with the concomitant therapeutic implications in the clinic.
UR - http://www.scopus.com/inward/record.url?scp=84937551237&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2015.05.009
DO - 10.1016/j.immuni.2015.05.009
M3 - Article
C2 - 26070485
AN - SCOPUS:84937551237
SN - 1074-7613
VL - 42
SP - 1143
EP - 1158
JO - Immunity
JF - Immunity
IS - 6
ER -